. "Suppl. 2" . . "RIV/00023752:_____/02:00000210" . "Antidepresiva v l\u00E9\u010Db\u011B depresivn\u00ED poruchy v t\u011Bhotenstv\u00ED a po porodu"@cs . . "1"^^ . . "11-18" . "P(LN00B122)" . "Psychiatrie" . "7"^^ . . "pregnancy; breastfeeding; antidepressants; depression in pregnancy; postpartum depression; risk factors; principles of treatment"@en . . "0"^^ . "1"^^ . "0"^^ . "Antidepressants in the treeatment of depressive disorder during pregnancy and lactation"@en . . . . "6" . "V \u00FAvodu \u010Dl\u00E1nku je \u010Dl\u00E1nku je charakterizov\u00E1na depresivn\u00ED porucha v t\u011Bhotenstv\u00ED a po porodu a jsou shrnuty rizikov\u00E9 faktory jejich vzniku. Autor kr\u00E1tce rekapituluje v\u00FDsledky klinick\u00FDch studi\u00ED s pou\u017Eit\u00EDm tricyklick\u00FDch antidepresiv, selektivn\u00EDch inhibitor\u016F zp\u011Btn\u00E9ho vst\u0159eb\u00E1v\u00E1n\u00ED serotoninu a tzv.%22nov\u00FDch antidepresiv%22 b\u011Bhem t\u011Bhotenstv\u00ED a po porodu a uv\u00E1d\u00ED hlavn\u00ED rizika jejich u\u017Eit\u00ED v t\u011Bchto obdob\u00EDch /teratogenicita, perinat\u00E1ln\u00ED toxicita, behavior\u00E1ln\u00ED toxicita atd./ a p\u0159i kojen\u00ED. V hlavn\u00ED \u010D\u00E1sti \u010Dl\u00E1nku jsou uvedeny a diskutov\u00E1ny z\u00E1kladn\u00ED z\u00E1sady l\u00E9\u010Dby depresivn\u00ED poruchy v t\u011Bhotenstv\u00ED /informace pacientky, volba l\u00E9\u010Dby, volba antidepresiva a jeho d\u00E1vkov\u00E1n\u00ED a prevence vzniku poporodn\u00ED deprese/ a p\u0159i kojen\u00ED." . "Antidepresiva v l\u00E9\u010Db\u011B depresivn\u00ED poruchy v t\u011Bhotenstv\u00ED a po porodu" . "1211-7579" . . . "Antidepressants in the treeatment of depressive disorder during pregnancy and lactation"@en . "638535" . . . "CZ - \u010Cesk\u00E1 republika" . "Bare\u0161, Martin" . . . . "Main characteristics of depressive disorder during pregnancy and postpartum depression and risk factors of relapse of depression in these periods are summarized. The author reviews results of clinical trials of tricyclic antidepressants, selective serotonin reuptake inhibitors and so called %22newer antidepressants%22 used during pregnancy; presents main risks of their use during this period and after delivery /teratogenicity, perinatal toxicity, behavioural teratogenicity etc./. Risks for nursing infants are also resumed. The basic principles of pharmacological treatment of depression during pregnancy and breastfeeding /patient\u00B4s information, choice of treatment, choice of antidepressant, dosage of antidepressant, and prevention of postpartum depression/ are discussed."@en . "[A10544B5303B]" . "RIV/00023752:_____/02:00000210!RIV/2003/MSM/L28003/N" . . . "Antidepresiva v l\u00E9\u010Db\u011B depresivn\u00ED poruchy v t\u011Bhotenstv\u00ED a po porodu"@cs . . "Antidepresiva v l\u00E9\u010Db\u011B depresivn\u00ED poruchy v t\u011Bhotenstv\u00ED a po porodu" .